Actinium Pharmaceuticals, Inc. (Delaware) (ATNM)


Actinium Pharmaceuticals, Inc. (Delaware) (ATNM)

$0.24 USD

0.01 (4.35%)

Updated Sep 20 12:00am

Add ATNM to Watchlist
Sign Up

Overall POWR Rating


POWR Components:

 Trade Grade  Buy & Hold Grade  Peer Grade  Industry Rank


Industry Rank:

Ranked of 329 in Biotech

See all “A” rated Strong Buy stocks

ATNM Daily Price Range
ATNM 52-Week Price Range

ATNM Stock Chart More Charts


ATNM Price/Volume Stats

Current price $0.24
Prev. close $0.23
Day low $0.22
Day high $0.24
50-day MA $0.23
200-day MA $0.37
52-week high $0.87
52-week low $0.19
Volume 371,400
Avg. volume 1,032,890
Dividend yield N/A
Market Cap 38.98M

Actinium Pharmaceuticals, Inc. (Delaware) (ATNM) Company Bio


Actinium Pharmaceuticals, Inc., a biopharmaceutical company, develops targeted payload immunotherapeutics for the treatment of advanced cancers. The company’s targeted radio immunotherapy products are based on its proprietary delivery platform for the therapeutic utilization of alpha-emitting Actinium-225 and Bismuth-213, and certain beta emitting radiopharmaceuticals in conjunction with monoclonal antibodies. The company was founded in 2000 and is based in New York City, New York.





ATNM News Stream


Event/Time News Detail
Loading, please wait...

ATNM Social Stream


Loading social stream, please wait...

View Full ATNM Social Stream

ATNM Returns

1-mo -3.03%
3-mo -9.40%
6-mo -48.94%
1-year -67.57%
3-year -86.29%
5-year -96.14%
YTD -38.46%
2018 -40.91%
2017 -24.14%
2016 -73.07%
2015 -45.16%
2014 0.00%

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!



Page generated in 0.4949 seconds.